Skip to main content
. 2021 Apr 7;114(1):29–41. doi: 10.1093/ajcn/nqab051

TABLE 2.

Sociodemographic characteristics and functional outcomes by wave of follow-up1

Baseline (n = 5725) Wave 2 (n = 5337) Wave 3 (n = 4419) Wave 4 (n = 3980) Wave 5 (n = 1865)
Age, y, median (IQR) 75.0 (71.6–79.0) 76.0 (73.0–80.0) 78.4 (76.0–82.0) 80.0 (77.2–83.3) 82.0 (80.0–84.0)
Females, % (n) 53.0 (3035) 53.5 (2856) 54.3 (2398) 54.6 (2172) 54.9 (1023)
Cohort, % (n)
 Health ABC 46.5 (2660) 46.6 (2487) 53.2 (2353) 52.4 (2085) 100.0 (1865)
 NuAge 30.1 (1726) 31.2 (1666) 36.4 (1610) 39.4 (1567) 0.0 (0)
 LASA 10.8 (620) 11.3 (602) 0.0 (0) 0.0 (0) 0.0 (0)
 N85+ 12.6 (719) 10.9 (582) 10.3 (456) 8.2 (328) 0.0 (0)
Education, % (n)
 Low 31.9 (1822) 31.0 (1651) 30.9 (1366) 30.4 (1208) 20.5 (382)
 Medium 37.7 (2156) 38.0 (2025) 35.1 (1551) 35.2 (1400) 32.4 (603)
 High 30.4 (1741) 31.0 (1655) 33.9 (1499) 34.4 (1368) 47.1 (878)
Multimorbidity, % (n) 51.0 (2784) 55.7 (2856) 56.1 (2396) 57.7 (2147) 58.9 (1099)
Cognition, % (n)
 Low 29.9 (1660) 31.4 (1475) 30.8 (1212) 36.6 (1201) 37.1 (538)
 Medium 41.7 (2319) 38.7 (1817) 38.0 (1498) 39.5 (1298) 31.9 (462)
 High 28.4 (1579) 29.8 (1399) 31.2 (1230) 23.9 (786) 31.0 (449)
Smokers, % (n) 8.5 (488) 7.7 (396) 6.6 (282) 6.0 (224) 7.0 (130)
Alcohol drinkers, % (n) 44.5 (2545) 45.3 (2359) 40.6 (1738) 41.7 (1574) 37.8 (705)
Energy intake, z-score (mean ± SD) −0.0 ± 1.0 −0.0 ± 1.0 −0.0 ± 1.0 −0.0 ± 1.0 −0.0 ± 1.0
Protein intake, g/kg BW/d, % (n)
 <0.8 33.6 (1924) 34.0 (1752) 36.8 (1566) 36.7 (1373) 45.5 (848)
 0.8–0.99 23.3 (1332) 23.2 (1198) 22.9 (976) 22.4 (838) 21.2 (395)
 1.0–1.19 19.3 (1107) 19.0 (981) 18.2 (773) 18.5 (691) 15.7 (292)
 ≥1.2 23.8 (1362) 23.8 (1227) 22.1 (942) 22.5 (842) 17.7 (330)
Protein intake, g/kg aBW/d, % (n)
 <0.8 27.6 (1579) 28.1 (1427) 30.4 (1293) 30.0 (1117) 39.4 (734)
 0.8–0.99 23.3 (1335) 23.1 (1173) 24.5 (1043) 23.7 (881) 22.6 (421)
 1.0–1.19 21.3 (1218) 20.8 (1056) 19.7 (836) 20.9 (777) 17.4 (324)
 ≥1.2 27.8 (1593) 27.9 (1415) 25.4 (1078) 25.5 (948) 20.7 (386)
Physical activity, % (n)
 Low 32.3 (1849) 37.9 (1933) 44.8 (1848) 43.7 (1541) 51.0 (870)
 Medium 33.8 (1935) 39.7 (2025) 31.2 (1287) 32.0 (1127) 30.1 (514)
 High 33.9 (1937) 22.5 (1146) 24.1 (993) 24.3 (856) 18.9 (322)
Walking speed, m/s (mean ± SD) 1.06 ± 0.28 1.06 ± 0.29 1.03 ± 0.27 1.01 ± 0.25 1.03 ± 0.23
Walking speed, z-score (mean ± SD) −0.00 ± 1.00 −0.02 ± 1.00 −0.14 ± 1.05 −0.28 ± 1.06 −0.53 ± 1.08
Mobility limitation, % (n)
 Difficulty walking >200 m 18.0 (1031) 21.2 (1048) 25.2 (981) 30.2 (1092) 35.4 (605)
 Difficulty climbing stairs 21.3 (1208) 24.2 (1233) 30.0 (1246) 31.5 (1129) 25.5 (414)
1

Not all waves are at the same time of follow-up among cohorts. In Health ABC the necessary variables were available at year 2 (operationalized as baseline), 4 (wave 2), 6 (wave 3), 8 (wave 4), and 10 (wave 5). In NuAge data were available at year 1 (baseline), 2 (wave 2), 3 (wave 3), and 4 (wave 4). In LASA variables were available at wave 3B (baseline) and at wave I after 3 y (wave 2). The Newcastle 85+ has data at baseline, after 18 mo (wave 2), after 36 mo (wave 3), and after 60 mo (wave 4). Cognition was assessed with the Mini-Mental State Examination. Smokers and alcohol drinkers represent current consumers. z-scores and tertiles are cohort-specific. aBW, adjusted body weight; BW, body weight; Health ABC, Health, Aging and Body Composition Study; LASA, Longitudinal Aging Study Amsterdam; N85+, Newcastle 85+ Study; NuAge, Quebec Longitudinal Study on Nutrition and Successful Aging.